DK1015494T3 - Fremgangsmåde til fremstilling af katalytiske antistoffer - Google Patents

Fremgangsmåde til fremstilling af katalytiske antistoffer

Info

Publication number
DK1015494T3
DK1015494T3 DK98943578T DK98943578T DK1015494T3 DK 1015494 T3 DK1015494 T3 DK 1015494T3 DK 98943578 T DK98943578 T DK 98943578T DK 98943578 T DK98943578 T DK 98943578T DK 1015494 T3 DK1015494 T3 DK 1015494T3
Authority
DK
Denmark
Prior art keywords
growth factor
present
factor precursor
catalytic antibodies
nucleic acid
Prior art date
Application number
DK98943578T
Other languages
Danish (da)
English (en)
Inventor
Herbert Rudolf Treutlein
Gabriele Maria Suess
David Mathew Tarlinton
Frank Koentgen
Original Assignee
Frank Koentgen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frank Koentgen filed Critical Frank Koentgen
Application granted granted Critical
Publication of DK1015494T3 publication Critical patent/DK1015494T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/624—Disulfide-stabilized antibody (dsFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98943578T 1997-09-19 1998-09-18 Fremgangsmåde til fremstilling af katalytiske antistoffer DK1015494T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO9306A AUPO930697A0 (en) 1997-09-19 1997-09-19 Catalytic antibodies and a method of producing same

Publications (1)

Publication Number Publication Date
DK1015494T3 true DK1015494T3 (da) 2006-05-01

Family

ID=3803589

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98943578T DK1015494T3 (da) 1997-09-19 1998-09-18 Fremgangsmåde til fremstilling af katalytiske antistoffer

Country Status (12)

Country Link
US (3) US6590080B1 (fr)
EP (1) EP1015494B1 (fr)
AT (1) ATE312845T1 (fr)
AU (1) AUPO930697A0 (fr)
CA (1) CA2304365A1 (fr)
DE (1) DE69832804T2 (fr)
DK (1) DK1015494T3 (fr)
ES (1) ES2253824T3 (fr)
GB (1) GB2345694B (fr)
HK (1) HK1029350A1 (fr)
NZ (3) NZ503454A (fr)
WO (1) WO1999015563A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU731580B2 (en) * 1996-03-26 2001-04-05 Frank Koentgen Precursors of catalytic antibodies
EP1539959A2 (fr) * 2002-09-18 2005-06-15 Centre Hospitalier de l'Université de Montréal (CHUM) Analogues de ghrh
US7700097B2 (en) 2003-06-27 2010-04-20 Biogen Idec Ma Inc. Purification and preferential synthesis of binding molecules
WO2005047327A2 (fr) 2003-11-12 2005-05-26 Biogen Idec Ma Inc. Variants de polypeptide se liant au recepteur fc neonatal (fcrn), proteines de liaison fc dimeres et techniques associees
WO2005113584A1 (fr) * 2004-04-29 2005-12-01 Board Of Regents, University Of Texas System Methodes et compositions contenant des domaines liant les ig de la proteine l pour le ciblage specifique de cellule
KR100890463B1 (ko) * 2006-09-19 2009-03-26 성균관대학교산학협력단 동물 세포 감염 바이러스에 대한 항바이러스제
US10585098B2 (en) 2009-11-23 2020-03-10 The Johns Hopkins University Optimizing diagnostics for galactofuranose containing antigens
WO2011063395A2 (fr) * 2009-11-23 2011-05-26 The Johns Hopkins University Dispositif de flux latéral destiné au diagnostic d'infections microbiennes
US9738707B2 (en) 2011-07-15 2017-08-22 Biogen Ma Inc. Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto
EP2565667A1 (fr) 2011-08-31 2013-03-06 Friedrich-Alexander-Universität Erlangen-Nürnberg Évaluation de direction d'arrivée à l'aide de signaux audio filigranés et réseaux de microphone
EP3049111A2 (fr) * 2013-09-25 2016-08-03 Cytomx Therapeutics Inc. Substrats pour métalloprotéinases matricielles et autres fragments clivables et leurs procédés d'utilisation
WO2015095195A1 (fr) 2013-12-16 2015-06-25 The Johns Hopkins University Dosages de libération d'interféron gamma pour le diagnostic d'infections fongiques invasives
RU2016135239A (ru) 2014-01-31 2018-03-12 Сайтомкс Терапьютикс, Инк. Субстраты матриптазы и u-активатора плазминогена и другие расщепляемые остатки и способы их применения
MA41374A (fr) 2015-01-20 2017-11-28 Cytomx Therapeutics Inc Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0162920A1 (fr) * 1983-11-29 1985-12-04 IGEN, INC. (a California corporation) Procede de catalyse de reactions chimiques
US5126258A (en) * 1984-09-07 1992-06-30 Scripps Clinic And Research Foundation Molecules with antibody combining sites that exhibit catalytic properties
US4900674A (en) * 1987-05-28 1990-02-13 Scripps Clinic And Research Foundation Antibody combining sites that exhibit amide or ester synthase activity
US5190865A (en) * 1988-11-18 1993-03-02 The Regents Of The University Of California Antibody-enhanced stereospecific hydrolyses
US5215889A (en) * 1988-11-18 1993-06-01 The Regents Of The University Of California Catalytic and reactive polypeptides and methods for their preparation and use
US5219732A (en) * 1989-09-05 1993-06-15 The Regents Of The University Of California Antibody-mediated cofactor-driven reactions
US5187086A (en) * 1990-01-26 1993-02-16 Scripps Clinic And Research Foundation Molecules with antibody combining sites that catalyze hydrolysis reactions through use of a charged hapten
SE9002212D0 (sv) * 1990-06-21 1990-06-21 Hightech Receptor Ab Igg binding protein
JPH06510529A (ja) * 1991-08-05 1994-11-24 イゲン，インコーポレーテッド 目標とする触媒性たんぱく質により活性化されるプロドラッグ
IL104829A (en) * 1992-02-24 1999-04-11 Igen Inc Selection is based on a response to the expression and concentration of catalytic units
US5439812A (en) * 1992-04-08 1995-08-08 The Pennsylvania Research Corporation Antibodies catalyzing deamidation of proteins
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
GB9209804D0 (en) * 1992-05-07 1992-06-24 Health Lab Service Board Novel immunoglobulin binding proteins process for their production and recombinant dna molecules coding therefor
AU731580B2 (en) * 1996-03-26 2001-04-05 Frank Koentgen Precursors of catalytic antibodies
EP0935612A4 (fr) * 1996-03-26 2001-12-12 Amrad Operations Pty Ltd Precurseurs d'anticorps catalytiques
US7253178B2 (en) * 2001-03-28 2007-08-07 Eisai Co., Ltd. Carboxylic acids
TWI311133B (en) * 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
JPWO2002098840A1 (ja) * 2001-06-04 2004-09-16 エーザイ株式会社 カルボン酸誘導体及びその塩もしくはそのエステルからなる医薬
WO2003016265A1 (fr) * 2001-08-17 2003-02-27 Eisai Co., Ltd. Compose cyclique et agoniste du recepteur ppar

Also Published As

Publication number Publication date
US20030148484A1 (en) 2003-08-07
ES2253824T3 (es) 2006-06-01
HK1029350A1 (en) 2001-03-30
ATE312845T1 (de) 2005-12-15
WO1999015563A1 (fr) 1999-04-01
NZ503454A (en) 2004-01-30
GB0009758D0 (en) 2000-06-07
GB2345694A (en) 2000-07-19
EP1015494A4 (fr) 2001-12-12
EP1015494A1 (fr) 2000-07-05
US6590080B1 (en) 2003-07-08
AUPO930697A0 (en) 1997-10-09
WO1999015563A9 (fr) 1999-06-03
EP1015494B1 (fr) 2005-12-14
NZ524429A (en) 2004-06-25
US20090269355A1 (en) 2009-10-29
GB2345694B (en) 2002-07-17
CA2304365A1 (fr) 1999-04-01
DE69832804T2 (de) 2006-08-10
NZ515603A (en) 2003-04-29
DE69832804D1 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
DK1015494T3 (da) Fremgangsmåde til fremstilling af katalytiske antistoffer
BR0010806A (pt) Métodos e materiais para a sìntese de produtos orgânicos
MY162525A (en) Process for concentration of antibodies and therapeutic products thereof
RU94042224A (ru) Способ получения олигонуклеотидов и соответствующие промежуточные соединения
HU9303023D0 (en) Peptide nucleicadis and method for producing them
DK0853487T3 (da) Neutraliserende monoklonale antistoffer mod respiratorisk syncytial virus
DK0986644T3 (da) Fremstilling af erythropoietin ved endogen genaktivering med virale promotorer
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
EP1808180A3 (fr) GP 100 modifié et ses utilisations
ATE297750T1 (de) Verwendung von hsp70 protein
KR970705408A (ko) 헤모필루스 부착 및 침투 단백질(haemophilus adherence and penetration proteins)
WO2004102198A3 (fr) Selection des lymphocytes b avec specificite d'interet : procede de preparation et utilisation
GB2326643B (en) Precursors of catalytic antibodies
BR0212504A (pt) Materiais e métodos para vacina de células t autólogas
CO5650177A2 (es) Constructos geneticos y composiciones que comprenden rre y cte y usos de estos
ATE395422T1 (de) Chimäre antikörper zur abgabe von antigenen an selektierte zellen des immunsystems
ATE505550T1 (de) Fermentationsverfahren
WO2001030989A3 (fr) Procede de creation de populations divergentes de molecules et de proteines d'acide nucleique
DK1001929T3 (da) Fremgangsmåde til fremstilling af 3-cyano-2,4-dihalogen-5-flour-benzoesyrer
DK0505921T3 (da) Fremgangsmåde til fremstilling af modne polypeptider ved enzymatisk spaltning med faktor Xa
ES2177762T3 (es) Procedimiento para producir cis-2-hidrixi-l-prolina.
Parikh Purification and characterization of hemorrhagic factor from Crotalus atrox (Western diamondback rattlesnake) venom by high performance liquid chromatography (HPLC) and production of monoclonal antibody.
HUT53593A (en) Process for producing optically active n-(terc butoxy-carbonyl)-o-benzyl-serine and n-(terc butoxy-carbonyl)-o-benzyl-treonine
MX9802766A (es) Vacuna contra la influenza.